Merrill Goozner served as Editor of babyforyou.pro from December 2012 to April 2017. As Editor Emeritus, he continues to write a weekly column, participate in babyforyou.pro education, events and awards programs and provide guidance on coverage related to healthcare transformation issues. Over the course of his four decades in journalism, he served as a foreign, national and chief economics correspondent for the Chicago Tribune and professor of journalism at New York University. He is the author of The $800 Million Pill: The Truth Behind the Cost of New Drugs (University of California Press, 2004), and has contributed articles to numerous publications. Goozner earned a master's degree in journalism from Columbia University and a bachelor's in history from the University of Cincinnati, where he received the Distinguished Alumni Award in 2008.
Addressing the root causes of ill health requires being honest about the extent and location of the poverty, inequality and despair in our society. The bottom line is that improving the nation’s health is a political agenda.
Even if Congress prohibits rebates and requires drug companies to pass along every dime in savings to customers, which almost every CEO in attendance pledged to do, tens of millions of patients will still be hitting their out-of-pocket maximums.
Rural communities will feel the pain first. But it will also ripple through major cities, where the healthcare workforce has become highly dependent on a steady stream of physicians, nurses and support staff born in other countries.
Other populous states should take a close look at what California is doing. Smaller states may want to form compacts with their neighbors to pursue something similar. Gov. Gavin Newsom has offered a practical approach to achieving more reasonable drug pricing.
For decades, demographers and economists have predicted the gray tsunami of aging baby boomers would inevitably push healthcare spending over 20% of GDP. But a new paper highlights some recent trends suggesting the future may not be as bleak and hard to manage as predicted.